Safety and tolerability of intravenous immunoglobulins
Martin, T.D.
Electroencephalography and Clinical Neurophysiology. Suppl 50: 514-520
1999
ISSN/ISBN: 0424-8155 PMID: 10689502 Document Number: 509281
Document emailed within 1 workday
Related Documents
Papas, A.S.; Martuscelli, G.; Singh, M.L.; Stone, C.; Bartizek, R.D.; Topmiller, K.J.; Biesbrock, A.R.; Walters, P.A. 2002: A study to assess the safety and tolerability of three toothbrushes Journal of Clinical Dentistry 13(5): 203-206Creatsas, G.; Elsheikh, A.; Colin, P. 2002: Safety and tolerability of the new contraceptive sponge Protectaid European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 7(2): 91-95
Creatsas, G.; Elsheikh, A.; Colin, P. 2002: Safety and tolerability of the new contraceptive sponge Protectaid European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 7(2): 91-95
Leroy, O.; Beuscart, C.; Sivery, B.; Senneville, E.; Mouton, Y. 1989: Efficacy and tolerability of intravenous ofloxacin. a French multicenter study of 273 patients Presse Medicale 18(42): 2050-2054
Pavicic, T. 2013: Calcium hydroxylapatite filler: an overview of safety and tolerability Journal of Drugs in Dermatology: Jdd 12(9): 996-1002
Mian, M.; Beghé, F.; Caprio, A.; Aloj, R.; Bertelli, A. 1991: Tolerability and safety of clodronate therapy in bone diseases International Journal of Clinical Pharmacology Research 11(2): 107-114
Duse, M.; Plebani, A.; Crispino, P.; Ugazio, A.G. 1991: Use of intravenous immunoglobulins in pediatrics La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 13(2): 117-125
Anand, K.S.; Dhikav, V.; Prasad, A.; Shewtengna 2011: Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia Journal of the Indian Medical Association 109(4): 264-266
Bazin, C.; Lecaille, C.; Lestrade, E.; Rech, G.; Colpaert, M.H. 2000: Methods of administration: intravenous immunoglobulins Revue de l'Infirmiere 63: 37-39
Cabrera Chaves, T.; Simón Marco, M.A.; Gomollón García, F.; Botella Esteban, M.T.; Uribarrena Echebarría, R. 1996: Hepatitis C following administration of intravenous immunoglobulins Gastroenterologia y Hepatologia 19(6): 305-308
Poehlau, D.; Postert, T.; Rieks, M.; Baier, J.; Nastos, I.; Amoiridis, G.; Schimrigk, S.; Hoffmann, V.; Przuntek, H. 1996: Mechanisms of action of intravenous immunoglobulins Fortschritte der Medizin 114(31): 420-424
Mselati, J.C.; Carlier, J.C.; Routon, M.C.; Noui Mehidi, F.; de Gennes, C. 1992: Intravenous immunoglobulins and aseptic meningitis Archives Francaises de Pediatrie 49(3): 216
Wurzer, H.; Schutze, K.; Bethke, T.; Fischer, R.; Luhmann, R.; Riesenhuber, C. 1999: Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group Hepato-Gastroenterology 46(27): 1809-1815
Del Priore, G.; Malanowska-Stega, J.; Shalaby, S.W.; Richman, S. 2009: A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring Journal of Reproductive Medicine 54(11-12): 685-690
Tukei, V.J.; Asiimwe, A.; Maganda, A.; Atugonza, R.; Sebuliba, I.; Bakeera-Kitaka, S.; Musoke, P.; Kalyesubula, I.; Kekitiinwa, A. 2012: Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda Journal of Acquired Immune Deficiency Syndromes 59(3): 274-280
Constenla, I.R.; Pato, A.P.; Hernando, I.C.; Gonzalez, J.R.L. 2014: Safety and Tolerability of Transdermal Rotigotine in a Clinical Practice Cohort for 2 Years World Journal of Neuroscience 04(05): 443-449
Mayer, K.H.; Peipert, J.; Fleming, T.; Fullem, A.; Moench, T.; Cu-Uvin, S.; Bentley, M.; Chesney, M.; Rosenberg, Z. 2001: Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 32(3): 476-482
Haymann, J.P.; Glotz, D. 1999: Intravenous polyclonal immunoglobulins (IVIG): what use in transplantation? Nephrologie 20(3): 139-143
Lewandowicz-Uszyńska, A.; Jankowski, A. 2011: The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 30(180): 409-412
Popescu, V.; Bleahu, D. 1992: The indications for intravenous immunoglobulins in pediatric practice Pediatrie 41(1): 37-45